You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 6, December 1951 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TOCOPHEROLS IN TREATMENT OF PRIMARY FIBROSITIS

Including Dupuytren's Contracture, Periarthritis of the Shoulders, and Peyronie's Disease

CHARLES LeROY STEINBERG, M.D.

AMA Arch Surg. 1951;63(6):824-833.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CONTINUED observations over the past decade of the clinical value of the tocopherols (vitamin E) in the treatment of primary fibrositis have yielded sufficient promising results to warrant a review at the present time. Thomson,1 in commenting on this subject, wrote the following sentence: "In fact, the general response has been so good that to assert that vitamin E has a specific effect on Dupuytren's contracture does not appear to be unduly reckless."

The results reported by Thomson concerned cases of Dupuytren's contracture involving 22 hands that were treated with vitamin E. All patients except one were treated with ephynal, 4 (50 mg.) tablets being the daily dose. The duration of the period of treatment varied from 12 to 20 weeks. The majority were treated for 20 weeks. He divided the severity of the Dupuytren contracture into Groups A, B, and C. Group A consisted of the early cases . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, N. Y.

Dr. Steinberg is Director of the Arthritis Clinic, Associate Chief of Medicine, Rochester General Hospital.


Footnotes

This study has been aided by a Grant from the Squibb Institute of Medical Research.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1951 American Medical Association. All Rights Reserved.